semaglutide on shortage list fda status january 2025 Federal judge upholds FDA's removal of Ozempic, Wegovy from drug GLP-1 No Longer FDA's – fda ends semaglutide Shortage Listing,

Carter R, Aldridge S, Page M, Parker S

Cognitive function was evaluated with the Brief Assessment of Cognition in Schizophrenia (BACS) battery of cognitive tests, which allows a measurement of global cognitive function across six domains: verbal memory with word list learning task, working memory with digit sequencing task, verbal fluency with controlled oral word association task, motor function with token motor task, attention and speed of information processing with symbol coding task and executive functions with Tower of London task

At higher dosages of ALA, side effects become more frequent

While the current market for these drugs in India is small, Elara Securities expects it to reach Rs 10,000 crore in the coming years